New photosensitizers for photodynamic therapy

Biochemical Journal

Volumn 473, Issue 4, 2016, Pages 347-364

  Abrahamse, Heidi ^a   Hamblin, Michael R ^b,c,d  

^a UNIVERSITY OF JOHANNESBURG   (South Africa)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

Naturally Occurring Photosensitizers; Photochemical Mechanisms; Photodynamic Therapy; Photosensitizers; Synthetic Dyes; Tetrapyrroles.

Indexed keywords

AMINOLEVULINIC ACID; ANTIINFECTIVE AGENT; BACTERIOCHLORIN; CHLORIN DERIVATIVE; CHLOROPHYLL; CURCUMIN; DYE; FULLERENE DERIVATIVE; HEME; HYPERICIN; HYPOCRELLIN A; HYPOCRELLIN B; PHOTOSENSITIZING AGENT; PHTHALOCYANINE DERIVATIVE; PORPHYRIN DERIVATIVE; QUANTUM DOT; REACTIVE OXYGEN METABOLITE; RIBOFLAVIN; ROSE BENGAL; SINGLET OXYGEN; SYNTHETIC DYE; TITANIUM DIOXIDE; TRANSITION ELEMENT; UNCLASSIFIED DRUG; UPCONVERSION NANOPARTICLE;

CANCER THERAPY; CELLULAR DISTRIBUTION; CHEMICAL STRUCTURE; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; ECHOGRAPHY; ENDOPLASMIC RETICULUM; FEMTOSECOND LASER; GOOD MANUFACTURING PRACTICE; LIGHT ABSORPTION; LIPOSOMAL DELIVERY; MICELLE; NANOTECHNOLOGY; NEAR INFRARED IMAGING SYSTEM; OXIDATION REDUCTION STATE; PHOTOCHEMICAL EFFICIENCY; PHOTOCHEMICAL INTERNALIZATION; PHOTOCHEMISTRY; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; REVIEW; THERANOSTIC NANOMEDICINE; HUMAN; NEOPLASMS; PHOTOCHEMOTHERAPY;

HUMANS; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 84958213684     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20150942     Document Type: Review

References (161)

1. Moan, J. and Peng, Q. (2003) An outline of the hundred-year history of PDT. Anticancer Res. 23, 3591-3600
2. Agostinis, P., Berg, K., Cengel, K.A., Foster, T.H., Girotti, A.W., Gollnick, S.O., Hahn, S.M., Hamblin, M.R., Juzeniene, A., Kessel, D. et al. (2011) Photodynamic therapy of cancer: An update. CA: Cancer J. Clin. 61, 250-281
3. Foote, C.S. (1968) Mechanisms of photosensitized oxidation. There are several different types of photosensitized oxidation which may be important in biological systems. Science 162, 963-970
4. Allison, R.R. and Sibata, C.H. (2010) Oncologic photodynamic therapy photosensitizers: A clinical review. Photodiagnosis Photodyn. Ther. 7, 61-75
5. Chen, B., Roskams, T. and de Witte, P.A. (2002) Antivascular tumor eradication by hypericin-mediated photodynamic therapy. Photochem. Photobiol. 76, 509-513
6. Garg, A.D., Nowis, D., Golab, J., Vandenabeele, P., Krysko, D.V. and Agostinis, P. (2010) Immunogenic cell death, DAMPs and anticancer therapeutics: An emerging amalgamation. Biochim. Biophys. Acta 1805, 53-71
7. Ascencio, M., Collinet, P., Farine, M.O. and Mordon, S. (2008) Protoporphyrin IX fluorescence photobleaching is a useful tool to predict the response of rat ovarian cancer following hexaminolevulinate photodynamic therapy. Lasers Surg. Med. 40, 332-341
8. De Rosa, F.S. and Bentley, M.V. (2000) Photodynamic therapy of skin cancers: sensitizers, clinical studies and future directives. Pharm. Res. 17, 1447-1455
9. Hamblin, M.R. and Newman, E.L. (1994) On the mechanism of the tumour-localising effect in photodynamic therapy. J. Photochem. Photobiol. B 23, 3-8
10. Iyer, A.K., Greish, K., Seki, T., Okazaki, S., Fang, J., Takeshita, K. and Maeda, H. (2007) Polymeric micelles of zinc protoporphyrin for tumor targeted delivery based on EPR effect and singlet oxygen generation. J. Drug Target. 15, 496-506
11. Kessel, D. (1992) The role of low-density lipoprotein in the biodistribution of photosensitizing agents. J. Photochem. Photobiol. B 14, 261-262
12. Dysart, J.S. and Patterson, M.S. (2005) Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro. Phys. Med. Biol. 50, 2597-2616
13. Moan, J., Berg, K., Kvam, E., Western, A., Malik, Z., Ruck, A. and Schneckenburger, H. (1989) Intracellular localization of photosensitizers. Ciba Found. Symp. 146, 95-107
14. Battersby, A.R. (2000) Tetrapyrroles: The pigments of life. Nat. Prod. Rep. 17, 507-526
15. Krammer, B. and Plaetzer, K. (2008) ALA and its clinical impact, from bench to bedside. Photochem. Photobiol. Sci. 7, 283-289
16. Alves, E., Faustino, M.A., Neves, M.G., Cunha, A., Tome, J. and Almeida, A. (2014) An insight on bacterial cellular targets of photodynamic inactivation. Future Med. Chem. 6, 141-164
17. Wagner, A., Denzer, U.W., Neureiter, D., Kiesslich, T., Puespoeck, A., Rauws, E.A., Emmanuel, K., Degenhardt, N., Frick, U., Beuers, U. et al. (2015) Temoporfin improves efficacy of photodynamic therapy in advanced biliary tract carcinoma: A multicenter prospective phase II study. Hepatology 62, 1456-1465
18. Chan, W.M., Lim, T.H., Pece, A., Silva, R. and Yoshimura, N. (2010) Verteporfin PDT for non-standard indications-A review of current literature. Graefes Arch. Clin. Exp. Ophthalmol. 248, 613-626
19. Biswas, R., Moon, J.H. and Ahn, J.C. (2014) Chlorin e6 derivative radachlorin mainly accumulates in mitochondria, lysosome and endoplasmic reticulum and shows high affinity toward tumors in nude mice in photodynamic therapy. Photochem. Photobiol. 90, 1108-1118
20. Romanko, Y.S., Tsyb, A.F., Kaplan, M.A. and Popuchiev, V.V. (2004) Effect of photodynamic therapy with photodithazine on morphofunctional parameters of M-1 sarcoma. Bull. Exp. Biol. Med. 138, 584-589
21. Chin, W.W., Heng, P.W., Bhuvaneswari, R., Lau, W.K. and Olivo, M. (2006) The potential application of chlorin e6-polyvinylpyrrolidone formulation in photodynamic therapy. Photochem. Photobiol. Sci. 5, 1031-1037
22. Nanashima, A. and Nagayasu, T. (2015) Current status of photodynamic therapy in digestive tract carcinoma in Japan. Int. J. Mol. Sci. 16, 3434-3440
23. Lobel, J., MacDonald, I.J., Ciesielski, M.J., Barone, T., Potter, W.R., Pollina, J., Plunkett, R.J., Fenstermaker, R.A. and Dougherty, T.J. (2001) 2-[1-Hexyloxyethyl]-2-devinyl pyropheophorbide-A (HPPH) in a nude rat glioma model: implications for photodynamic therapy. Lasers Surg. Med. 29, 397-405
24. authors, No (2004) Rostaporfin: PhotoPoint SnET2, Purlytin, Sn(IV) etiopurpurin, SnET2, tin ethyl etiopurpurin. Drugs R D 5, 58-61
25. Gross, S., Gilead, A., Scherz, A., Neeman, M. and Salomon, Y. (2003) Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI. Nat. Med. 9, 1327-1331
26. Azzouzi, A.R., Lebdai, S., Benzaghou, F. and Stief, C. (2015) Vascular-Targeted photodynamic therapy with TOOKAD Soluble in localized prostate cancer: standardization of the procedure. World J. Urol. 33, 937-944
27. Saavedra, R., Rocha, L.B., Dabrowski, J.M. and Arnaut, L.G. (2014) Modulation of biodistribution, pharmacokinetics, and photosensitivity with the delivery vehicle of a bacteriochlorin photosensitizer for photodynamic therapy. ChemMedChem 9, 390-398
28. Huang, Y.Y., Mroz, P., Zhiyentayev, T., Sharma, S.K., Balasubramanian, T., Ruzie, C., Krayer, M., Fan, D., Borbas, K.E., Yang, E. et al. (2010) In Vitro photodynamic therapy and quantitative structure-Activity relationship studies with stable synthetic near-infrared-Absorbing bacteriochlorin photosensitizers. J. Med. Chem. 53, 4018-4027
29. Huang, L., Krayer, M., Roubil, J.G., Huang, Y.Y., Holten, D., Lindsey, J.S. and Hamblin, M.R. (2014) Stable synthetic mono-substituted cationic bacteriochlorins mediate selective broad-spectrum photoinactivation of drug-resistant pathogens at nanomolar concentrations. J. Photochem. Photobiol. B 141, 119-127
30. Mroz, P., Huang, Y.Y., Szokalska, A., Zhiyentayev, T., Janjua, S., Nifli, A.P., Sherwood, M.E., Ruzie, C., Borbas, K.E., Fan, D. et al. (2010) Stable synthetic bacteriochlorins overcome the resistance of melanoma to photodynamic therapy. FASEB J. 24, 3160-3170
31. Roberts, W.G., Klein, M.K., Loomis, M., Weldy, S. and Berns, M.W. (1991) Photodynamic therapy of spontaneous cancers in felines, canines, and snakes with chloro-Aluminum sulfonated phthalocyanine. J. Natl. Cancer Inst. 83, 18-23
32. Schieweck, K., Capraro, H.G., Isele, U., van Hoogevest, P., Ochsner, M., Maurer, T. and Batt, E. (1994) CGP 55847, liposome-delivered zinc(II) phthalocyanine as phototherapeutic agent for tumours. Proc. SPIE 2078, 107-118
33. Anderson, C.Y., Freye, K., Tubesing, K.A., Li, Y.S., Kenney, M.E., Mukhtar, H. and Elmets, C.A. (1998) A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice. Photochem. Photobiol. 67, 332-336
34. Kinsella, T.J., Baron, E.D., Colussi, V.C., Cooper, K.D., Hoppel, C.L., Ingalls, S.T., Kenney, M.E., Li, X., Oleinick, N.L., Stevens, S.R. and Remick, S.C. (2011) Preliminary clinical and pharmacologic investigation of photodynamic therapy with the silicon phthalocyanine photosensitizer pc 4 for primary or metastatic cutaneous cancers. Front Oncol. 1, 14
35. Vecchio, D., Dai, T., Huang, L., Fantetti, L., Roncucci, G. and Hamblin, M.R. (2013) Antimicrobial photodynamic therapy with RLP068 kills methicillin-resistant Staphylococcus aureus and improves wound healing in a mouse model of infected skin abrasion PDT with RLP068/Cl in infected mouse skin abrasion. J. Biophotonics 6, 733-742
36. Mannucci, E., Genovese, S., Monami, M., Navalesi, G., Dotta, F., Anichini, R., Romagnoli, F. and Gensini, G. (2014) Photodynamic topical antimicrobial therapy for infected foot ulcers in patients with diabetes: A randomized, double-blind, placebo-controlled study-The D.A.N.T.E (Diabetic ulcer Antimicrobial New Topical treatment Evaluation) study. Acta Diabetol. 51, 435-440
37. Wainwright, M. and Crossley, K.B. (2002) Methylene Blue-A therapeutic dye for all seasons? J. Chemother. 14, 431-443
38. Tseng, S.P., Hung, W.C., Chen, H.J., Lin, Y.T., Jiang, H.S., Chiu, H.C., Hsueh, P.R., Teng, L.J. and Tsai, J.C. (2015) Effects of toluidine blue O (TBO)-photodynamic inactivation on community-Associated methicillin-resistant Staphylococcus aureus isolates. J. Microbiol. Immunol. Infect.
39. Tardivo, J.P., Adami, F., Correa, J.A., Pinhal, M.A. and Baptista, M.S. (2014) A clinical trial testing the efficacy of PDT in preventing amputation in diabetic patients. Photodiagnosis Photodyn. Ther. 11, 342-350
40. Graciano, T.B., Coutinho, T.S., Cressoni, C.B., Freitas Cde, P., Pierre, M.B., Pereira, S.A., Shimano, M.M., Frange, R.C. and Garcia, M.T. (2015) Using chitosan gels as a toluidine blue O delivery system for photodynamic therapy of buccal cancer: in vitro and in vivo studies. Photodiagnosis Photodyn. Ther. 12, 98-107
41. Morley, S., Griffiths, J., Philips, G., Moseley, H., O'Grady, C., Mellish, K., Lankester, C.L., Faris, B., Young, R.J., Brown, S.B. and Rhodes, L.E. (2013) Phase IIa randomized, placebo-controlled study of antimicrobial photodynamic therapy in bacterially colonized, chronic leg ulcers and diabetic foot ulcers: A new approach to antimicrobial therapy. Br. J. Dermatol. 168, 617-624
42. Verma, S., Sallum, U.W., Athar, H., Rosenblum, L., Foley, J.W. and Hasan, T. (2009) Antimicrobial photodynamic efficacy of side-chain functionalized benzo[a]phenothiazinium dyes. Photochem. Photobiol. 85, 111-118
43. Frimberger, A.E., Moore, A.S., Cincotta, L., Cotter, S.M. and Foley, J.W. (1998) Photodynamic therapy of naturally occurring tumors in animals using a novel benzophenothiazine photosensitizer. Clin. Cancer Res. 4, 2207-2218
44. Costa, A.C., Rasteiro, V.M., Pereira, C.A., Rossoni, R.D., Junqueira, J.C. and Jorge, A.O. (2012) The effects of rose bengal-And erythrosine-mediated photodynamic therapy on Candida albicans. Mycoses 55, 56-63
45. Xu, N., Yao, M., Farinelli, W., Hajjarian, Z., Wang, Y., Redmond, R.W. and Kochevar, I.E. (2015) Light-Activated sealing of skin wounds. Lasers Surg. Med. 47, 17-29
46. Panzarini, E., Inguscio, V., Fimia, G.M. and Dini, L. (2014) Rose Bengal acetate photodynamic therapy (RBAc-PDT) induces exposure and release of damage-Associated molecular patterns (DAMPs) in human HeLa cells. PLoS One 9, e105778
47. Cole, E.L., Arunkumar, E., Xiao, S., Smith, B.A. and Smith, B.D. (2012) Water-soluble, deep-red fluorescent squaraine rotaxanes. Org. Biomol. Chem. 10, 5769-5773
48. Hsueh, S.Y., Lai, C.C. and Chiu, S.H. (2010) Squaraine-based [2]rotaxanes that function as visibly active molecular switches. Chemistry 16, 2997-3000
49. Boens, N., Leen, V. and Dehaen, W. (2012) Fluorescent indicators based on BODIPY. Chem. Soc. Rev. 41, 1130-1172
50. Kamkaew, A., Lim, S.H., Lee, H.B., Kiew, L.V., Chung, L.Y. and Burgess, K. (2013) BODIPY dyes in photodynamic therapy. Chem. Soc. Rev. 42, 77-88
51. Segado, M. and Reguero, M. (2011) Mechanism of the photochemical process of singlet oxygen production by phenalenone. Phys. Chem. Chem. Phys. 13, 4138-4148
52. Cieplik, F., Spath, A., Regensburger, J., Gollmer, A., Tabenski, L., Hiller, K.A., Baumler, W., Maisch, T. and Schmalz, G. (2013) Photodynamic biofilm inactivation by SAPYR-An exclusive singlet oxygen photosensitizer. Free Radic. Biol. Med. 65, 477-487
53. Spath, A., Leibl, C., Cieplik, F., Lehner, K., Regensburger, J., Hiller, K.A., Baumler, W., Schmalz, G. and Maisch, T. (2014) Improving photodynamic inactivation of bacteria in dentistry: highly effective and fast killing of oral key pathogens with novel tooth-colored type-II photosensitizers. J. Med. Chem. 57, 5157-5168
54. Gill, M.R. and Thomas, J.A. (2012) Ruthenium(II) polypyridyl complexes and DNA-from structural probes to cellular imaging and therapeutics. Chem. Soc. Rev. 41, 3179-3192
55. Fong, J., Kasimova, K., Arenas, Y., Kaspler, P., Lazic, S., Mandel, A. and Lilge, L. (2015) A novel class of ruthenium-based photosensitizers effectively kills in vitro cancer cells and in vivo tumors. Photochem. Photobiol. Sci. 14, 2014-2023
56. Angeles-Boza, A.M., Bradley, P.M., Fu, P.K., Wicke, S.E., Bacsa, J., Dunbar, K.R. and Turro, C. (2004) DNA binding and photocleavage in vitro by new dirhodium(II) dppz complexes: correlation to cytotoxicity and photocytotoxicity. Inorg. Chem. 43, 8510-8519
57. Li, Y., Tan, C.P., Zhang, W., He, L., Ji, L.N. and Mao, Z.W. (2015) Phosphorescent iridium(III)-bis-N-heterocyclic carbene complexes as mitochondria-Targeted theranostic and photodynamic anticancer agents. Biomaterials 39, 95-104
58. Angeles-Boza, A.M., Bradley, P.M., Fu, P.K., Shatruk, M., Hilfiger, M.G., Dunbar, K.R. and Turro, C. (2005) Photocytotoxicity of a new Rh2(II, II) complex: increase in cytotoxicity upon irradiation similar to that of PDT agent hematoporphyrin. Inorg. Chem. 44, 7262-7264
59. To, W.P., Zou, T., Sun, R.W. and Che, C.M. (2013) Light-induced catalytic and cytotoxic properties of phosphorescent transition metal compounds with a d8 electronic configuration. Philos. Trans. A. Math. Phys. Eng. Sci. 371, 20120126
60. Theodossiou, T.A., Hothersall, J.S., De Witte, P.A., Pantos, A. and Agostinis, P. (2009) The multifaceted photocytotoxic profile of hypericin. Mol. Pharm. 6, 1775-1789
61. Liu, X., Jiang, C., Li, Y., Liu, W., Yao, N., Gao, M., Ji, Y., Huang, D., Yin, Z., Sun, Z., Ni, Y. and Zhang, J. (2015) Evaluation of hypericin: effect of aggregation on targeting biodistribution. J. Pharm. Sci. 104, 215-222
62. Zheng, Y., Yin, G., Le, V., Zhang, A., Lu, Y., Yang, M., Fei, Z. and Liu, J. (2014) Hypericin-based photodynamic therapy induces a tumor-specific immune response and an effective DC-based cancer immunotherapy. Biochem. Pharmacol.
63. Zhenjun, D. and Lown, J.W. (1990) Hypocrellins and their use in photosensitization. Photochem. Photobiol. 52, 609-616
64. Li, T., Hou, X., Deng, H., Zhao, J., Huang, N., Zeng, J., Chen, H. and Gu, Y. (2015) Liposomal hypocrellin B as a potential photosensitizer for age-related macular degeneration: pharmacokinetics, photodynamic efficacy, and skin phototoxicity in vivo. Photochem. Photobiol. Sci. 14, 972-981
65. Makdoumi, K., Backman, A., Mortensen, J. and Crafoord, S. (2010) Evaluation of antibacterial efficacy of photo-Activated riboflavin using ultraviolet light (UVA). Graefes Arch. Clin. Exp. Ophthalmol. 248, 207-212
66. Ettinger, A., Miklauz, M.M., Bihm, D.J., Maldonado-Codina, G. and Goodrich, R.P. (2012) Preparation of cryoprecipitate from riboflavin and UV light-Treated plasma. Transfus. Apher. Sci. 46, 153-158
67. Chan, T.C., Lau, T.W., Lee, J.W., Wong, I.Y., Jhanji, V. and Wong, R.L. (2015) Corneal collagen cross-linking for infectious keratitis: An update of clinical studies. Acta Ophthalmol.
68. Maisch, T., Eichner, A., Spath, A., Gollmer, A., Konig, B., Regensburger, J. and Baumler, W. (2014) Fast and effective photodynamic inactivation of multiresistant bacteria by cationic riboflavin derivatives. PLoS One 9, e111792
69. Ghosh, S., Banerjee, S. and Sil, P.C. (2015) The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update. Food Chem. Toxicol 83, 111-124
70. Wikene, K.O., Hegge, A.B., Bruzell, E. and Tonnesen, H.H. (2015) Formulation and characterization of lyophilized curcumin solid dispersions for antimicrobial photodynamic therapy (aPDT): studies on curcumin and curcuminoids LII. Drug Dev. Ind. Pharm. 41, 969-977
71. Bernd, A. (2014) Visible light and/or UVA offer a strong amplification of the anti-Tumor effect of curcumin. Phytochem. Rev. 13, 183-189
72. Leite, D.P., Paolillo, F.R., Parmesano, T.N., Fontana, C.R. and Bagnato, V.S. (2014) Effects of photodynamic therapy with blue light and curcumin as mouth rinse for oral disinfection: A randomized controlled trial. Photomed. Laser Surg. 32, 627-632
73. Sibani, S.A., McCarron, P.A., Woolfson, A.D. and Donnelly, R.F. (2008) Photosensitiser delivery for photodynamic therapy. Part 2: systemic carrier platforms. Expert Opin. Drug Deliv. 5, 1241-1254
74. Sato, K., Nagaya, T., Choyke, P.L. and Kobayashi, H. (2015) Near infrared photoimmunotherapy in the treatment of pleural disseminated NSCLC: preclinical experience. Theranostics 5, 698-709
75. Hamblin, M.R., Miller, J.L. and Hasan, T. (1996) Effect of charge on the interaction of site-specific photoimmunoconjugates with human ovarian cancer cells. Cancer Res. 56, 5205-5210
76. You, H., Yoon, H.E., Jeong, P.H., Ko, H., Yoon, J.H. and Kim, Y.C. (2015) Pheophorbide-A conjugates with cancer-Targeting moieties for targeted photodynamic cancer therapy. Bioorg. Med. Chem. 23, 1453-1462
77. Hamblin, M.R. and Newman, E.L. (1994) Photosensitizer targeting in photodynamic therapy. I. Conjugates of haematoporphyrin with albumin and transferrin. J. Photochem. Photobiol. B 26, 45-56
78. Sobolev, A.S., Akhlynina, T.V., Yachmenev, S.V., Rosenkranz, A.A. and Severin, E.S. (1992) Internalizable insulin-BSA-chlorin E6 conjugate is a more effective photosensitizer than chlorin E6 alone. Biochem. Int. 26, 445-450
79. Hamblin, M.R. and Newman, E.L. (1994) Photosensitizer targeting in photodynamic therapy. II. Conjugates of haematoporphyrin with serum lipoproteins. J. Photochem. Photobiol. B 26, 147-157
80. Park, S.Y., Baik, H.J., Oh, Y.T., Oh, K.T., Youn, Y.S. and Lee, E.S. (2011) A smart polysaccharide/drug conjugate for photodynamic therapy. Angew. Chem. Int. Ed. Engl. 50, 1644-1647
81. Kascakova, S., Hofland, L.J., De Bruijn, H.S., Ye, Y., Achilefu, S., van der Wansem, K., van der Ploeg-van den Heuvel, A., van Koetsveld, P.M., Brugts, M.P., van der Lelij, A.J. et al. (2014) Somatostatin analogues for receptor targeted photodynamic therapy. PLoS One 9, e104448
82. Li, D., Li, P., Lin, H., Jiang, Z., Guo, L. and Li, B. (2013) A novel chlorin-PEG-folate conjugate with higher water solubility, lower cytotoxicity, better tumor targeting and photodynamic activity. J. Photochem. Photobiol. B 127, 28-37
83. Staggers, N., McCasky, T., Brazelton, N. and Kennedy, R. (2008) Nanotechnology: The coming revolution and its implications for consumers, clinicians, and informatics. Nurs. Outlook 56, 268-274
84. Brown, E.M., Allen, L.L., Pyles, H., Solis, J., Wileman, T.A. and Willadsen, G.B. (2013) Advancements in using TiO2 bionanoconjugates for precision degradation of intracellular biological structures. J. Biomed. Nanotechnol. 9, 539-550
85. Huang, Y.Y., Sharma, S.K., Dai, T., Chung, H., Yaroslavsky, A., Garcia-Diaz, M., Chang, J., Chiang, L.Y. and Hamblin, M.R. (2012) Can nanotechnology potentiate photodynamic therapy? Nanotechnol. Rev. 1, 111-146
86. Mroz, P., Tegos, G.P., Gali, H., Wharton, T., Sarna, T. and Hamblin, M.R. (2007) Photodynamic therapy with fullerenes. Photochem. Photobiol. Sci. 6, 1139-1149
87. Ge, J., Lan, M., Zhou, B., Liu, W., Guo, L., Wang, H., Jia, Q., Niu, G., Huang, X., Zhou, H. et al. (2014) A graphene quantum dot photodynamic therapy agent with high singlet oxygen generation. Nat. Commun. 5, 4596
88. Master, A., Livingston, M. and Sen Gupta, A. (2013) Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challenges. J. Control. Release 168, 88-102
89. Perni, S., Prokopovich, P., Pratten, J., Parkin, I.P. and Wilson, M. (2011) Nanoparticles: Their potential use in antibacterial photodynamic therapy. Photochem. Photobiol. Sci. 10, 712-720
90. Sadasivam, M., Avci, P., Gupta, G.K., Lakshmanan, S., Chandran, R., Huang, Y.Y., Kumar, R. and Hamblin, M.R. (2013) Self-Assembled liposomal nanoparticles in photodynamic therapy. Eur. J. Nanomed. 5, 115-129
91. Avci, P., Erdem, S.S. and Hamblin, M.R. (2014) Photodynamic therapy: one step ahead with self-Assembled nanoparticles. J. Biomed. Nanotechnol. 10, 1937-1952
92. Yamakoshi, Y., Umezawa, N., Ryu, A., Arakane, K., Miyata, N., Goda, Y., Masumizu, T. and Nagano, T. (2003) Active oxygen species generated from photoexcited fullerene (C60) as potential medicines: O2-versus 1O2. J. Am. Chem. Soc. 125, 12803-12809
93. Mroz, P., Pawlak, A., Satti, M., Lee, H., Wharton, T., Gali, H., Sarna, T. and Hamblin, M.R. (2007) Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism. Free Radic. Biol. Med. 43, 711-719
94. Tegos, G.P., Demidova, T.N., Arcila-Lopez, D., Lee, H., Wharton, T., Gali, H. and Hamblin, M.R. (2005) Cationic fullerenes are effective and selective antimicrobial photosensitizers. Chem. Biol. 12, 1127-1135
95. Mroz, P., Xia, Y., Asanuma, D., Konopko, A., Zhiyentayev, T., Huang, Y.Y., Sharma, S.K., Dai, T., Khan, U.J., Wharton, T. and Hamblin, M.R. (2011) Intraperitoneal photodynamic therapy mediated by a fullerene in a mouse model of abdominal dissemination of colon adenocarcinoma. Nanomedicine 7, 965-974
96. Lu, Z., Dai, T., Huang, L., Kurup, D.B., Tegos, G.P., Jahnke, A., Wharton, T. and Hamblin, M.R. (2010) Photodynamic therapy with a cationic functionalized fullerene rescues mice from fatal wound infections. Nanomedicine (Lond.) 5, 1525-1533
97. Foster, H.A., Ditta, I.B., Varghese, S. and Steele, A. (2011) Photocatalytic disinfection using titanium dioxide: spectrum and mechanism of antimicrobial activity. Appl. Microbiol. Biotechnol. 90, 1847-1868
98. Sette, A., Spadavecchia, J., Landoulsi, J., Casale, S., Haye, B., Crociani, O. and Arcangeli, A. (2013) Development of novel anti-Kv 11.1 antibody-conjugated PEG-TiO nanoparticles for targeting pancreatic ductal adenocarcinoma cells. J. Nanopart. Res. 15, 2111
99. Feng, X., Zhang, S. and Lou, X. (2013) Controlling silica coating thickness on TiO2 nanoparticles for effective photodynamic therapy. Colloids Surf. B Biointerfaces 107, 220-226
100. Kotagiri, N., Sudlow, G.P., Akers, W.J. and Achilefu, S. (2015) Breaking the depth dependency of phototherapy with Cerenkov radiation and low-radiance-responsive nanophotosensitizers. Nat. Nanotechnol. 10, 370-379
101. Maksimov, E.G., Gvozdev, D.A., Strakhovskaya, M.G. and Paschenko, V.Z. (2015) Hybrid structures of polycationic aluminum phthalocyanines and quantum dots. Biochemistry (Mosc.) 80, 323-331
102. Shao, L., Gao, Y. and Yan, F. (2011) Semiconductor quantum dots for biomedicial applications. Sensors (Basel) 11, 11736-11751
103. Zhou, L., Zhou, L., Ge, X., Zhou, J., Wei, S. and Shen, J. (2015) Multicolor imaging and the anticancer effect of a bifunctional silica nanosystem based on the complex of graphene quantum dots and hypocrellin A. Chem. Commun. (Camb.) 51, 421-424
104. Dou, Q.Q., Rengaramchandran, A., Selvan, S.T., Paulmurugan, R. and Zhang, Y. (2015) Core-shell upconversion nanoparticle-semiconductor heterostructures for photodynamic therapy. Sci. Rep. 5, 8252
105. Ai, F., Ju, Q., Zhang, X., Chen, X., Wang, F. and Zhu, G. (2015) A core-shell-shell nanoplatform upconverting near-infrared light at 808 nm for luminescence imaging and photodynamic therapy of cancer. Sci. Rep. 5, 10785
106. Berg, K., Nordstrand, S., Selbo, P.K., Tran, D.T., Angell-Petersen, E. and Hogset, A. (2011) Disulfonated tetraphenyl chlorin (TPCS2a), a novel photosensitizer developed for clinical utilization of photochemical internalization. Photochem. Photobiol. Sci. 10, 1637-1651
107. Selbo, P.K., Weyergang, A., Hogset, A., Norum, O.J., Berstad, M.B., Vikdal, M. and Berg, K. (2010) Photochemical internalization provides time-And space-controlled endolysosomal escape of therapeutic molecules. J. Control. Release 148, 2-12
108. Weyergang, A., Selbo, P.K., Berstad, M.E., Bostad, M. and Berg, K. (2011) Photochemical internalization of tumor-Targeted protein toxins. Lasers Surg. Med. 43, 721-733
109. Dietze, A., Bonsted, A., Hogset, A. and Berg, K. (2003) Photochemical internalization enhances the cytotoxic effect of the protein toxin gelonin and transgene expression in sarcoma cells. Photochem. Photobiol. 78, 283-289
110. Norum, O.J., Gaustad, J.V., Angell-Petersen, E., Rofstad, E.K., Peng, Q., Giercksky, K.E. and Berg, K. (2009) Photochemical internalization of bleomycin is superior to photodynamic therapy due to the therapeutic effect in the tumor periphery. Photochem. Photobiol. 85, 740-749
111. Jerjes, W., Upile, T., Radhi, H. and Hopper, C. (2011) Photodynamic therapy vs. photochemical internalization: The surgical margin. Head Neck Oncol. 3, 53
112. Boe, S.L. and Hovig, E. (2013) Enhancing nucleic acid delivery by photochemical internalization. Ther. Deliv. 4, 1125-1140
113. Mueller, G., Waldeck, W. and Braun, K. (2010) From green to red-To more dead? Autofluorescent proteins as photosensitizers. J. Photochem. Photobiol. B 98, 95-98
114. Bulina, M.E., Chudakov, D.M., Britanova, O.V., Yanushevich, Y.G., Staroverov, D.B., Chepurnykh, T.V., Merzlyak, E.M., Shkrob, M.A., Lukyanov, S. and Lukyanov, K.A. (2006) A genetically encoded photosensitizer. Nat. Biotechnol. 24, 95-99
115. Liao, Z.X., Li, Y.C., Lu, H.M. and Sung, H.W. (2014) A genetically-encoded KillerRed protein as an intrinsically generated photosensitizer for photodynamic therapy. Biomaterials 35, 500-508
116. Serebrovskaya, E.O., Ryumina, A.P., Boulina, M.E., Shirmanova, M.V., Zagaynova, E.V., Bogdanova, E.A., Lukyanov, S.A. and Lukyanov, K.A. (2014) Phototoxic effects of lysosome-Associated genetically encoded photosensitizer KillerRed. J. Biomed. Opt. 19, 071403
117. Williams, D.C., Bejjani, R.E., Ramirez, P.M., Coakley, S., Kim, S.A., Lee, H., Wen, Q., Samuel, A., Lu, H., Hilliard, M.A. and Hammarlund, M. (2013) Rapid and permanent neuronal inactivation in vivo via subcellular generation of reactive oxygen with the use of KillerRed. Cell Rep. 5, 553-563
118. Serebrovskaya, E.O., Gorodnicheva, T.V., Ermakova, G.V., Solovieva, E.A., Sharonov, G.V., Zagaynova, E.V., Chudakov, D.M., Lukyanov, S., Zaraisky, A.G. and Lukyanov, K.A. (2011) Light-induced blockage of cell division with a chromatin-Targeted phototoxic fluorescent protein. Biochem. J. 435, 65-71
119. Lee, H., Kim, S.A., Coakley, S., Mugno, P., Hammarlund, M., Hilliard, M.A. and Lu, H. (2014) A multi-channel device for high-density target-selective stimulation and long-Term monitoring of cells and subcellular features in C. elegans. Lab Chip 14, 4513-4522
120. Teh, C., Chudakov, D.M., Poon, K.L., Mamedov, I.Z., Sek, J.Y., Shidlovsky, K., Lukyanov, S. and Korzh, V. (2010) Optogenetic in vivo cell manipulation in KillerRed-expressing zebrafish transgenics. BMC Dev. Biol. 10, 110
121. Jewhurst, K., Levin, M. and McLaughlin, K.A. (2014) Optogenetic control of apoptosis in targeted tissues of Xenopus laevis embryos. J. Cell Death 7, 25-31
122. Byrne, L.C., Khalid, F., Lee, T., Zin, E.A., Greenberg, K.P., Visel, M., Schaffer, D.V. and Flannery, J.G. (2013) AAV-mediated, optogenetic ablation of Muller Glia leads to structural and functional changes in the mouse retina. PLoS One 8, e76075
123. Ryumina, A.P., Serebrovskaya, E.O., Shirmanova, M.V., Snopova, L.B., Kuznetsova, M.M., Turchin, I.V., Ignatova, N.I., Klementieva, N.V., Fradkov, A.F., Shakhov, B.E. et al. (2013) Flavoprotein miniSOG as a genetically encoded photosensitizer for cancer cells. Biochim. Biophys. Acta 1830, 5059-5067
124. Vatansever, F., Chandran, R., Sadasivam, M., Chiang, L.Y. and Hamblin, M.R. (2012) Multi-functionality in theranostic nanoparticles: is more always better? J. Nanomed. Nanotechnol. 3, e120
125. Rai, P., Mallidi, S., Zheng, X., Rahmanzadeh, R., Mir, Y., Elrington, S., Khurshid, A. and Hasan, T. (2010) Development and applications of photo-Triggered theranostic agents. Adv. Drug Deliv. Rev. 62, 1094-1124
126. Wang, S., Zhang, L., Dong, C., Su, L., Wang, H. and Chang, J. (2015) Smart pH-responsive upconversion nanoparticles for enhanced tumor cellular internalization and near-infrared light-Triggered photodynamic therapy. Chem. Commun. (Camb.) 51, 406-408
127. Fu, X.J., Zhu, Y.Q., Peng, Y.B., Chen, Y.S., Hu, Y.P., Lu, H.X., Yu, W.R., Fang, Y., Du, J.Z. and Yao, M. (2014) Enzyme activated photodynamic therapy for methicillin-resistant Staphylococcus aureus infection both inv itro and in vivo. J. Photochem. Photobiol. B 136, 72-80
128. Silva, A.K., Kolosnjaj-Tabi, J., Bonneau, S., Marangon, I., Boggetto, N., Aubertin, K., Clement, O., Bureau, M.F., Luciani, N., Gazeau, F. and Wilhelm, C. (2013) Magnetic and photoresponsive theranosomes: Translating cell-released vesicles into smart nanovectors for cancer therapy. ACS Nano 7, 4954-4966
129. Charron, D.M., Chen, J. and Zheng, G. (2015) Theranostic lipid nanoparticles for cancer medicine. Cancer Treat. Res. 166, 103-127
130. Aggarwal, A., Thompson, S., Singh, S., Newton, B., Moore, A., Gao, R., Gu, X., Mukherjee, S. and Drain, C.M. (2014) Photophysics of glycosylated derivatives of a chlorin, isobacteriochlorin and bacteriochlorin for photodynamic theragnostics: discovery of a two-photon-Absorbing photosensitizer. Photochem. Photobiol. 90, 419-430
131. Ogawa, K. and Kobuke, Y. (2013) Two-photon photodynamic therapy by water-soluble self-Assembled conjugated porphyrins. Biomed. Res. Int. 2013, 125658
132. Starkey, J.R., Rebane, A.K., Drobizhev, M.A., Meng, F., Gong, A., Elliott, A., McInnerney, K. and Spangler, C.W. (2008) New two-photon activated photodynamic therapy sensitizers induce xenograft tumor regressions after near-IR laser treatment through the body of the host mouse. Clin. Cancer Res. 14, 6564-6573
133. Rosenthal, I., Sostaric, J.Z. and Riesz, P. (2004) Sonodynamic therapy-A review of the synergistic effects of drugs and ultrasound. Ultrason. Sonochem. 11, 349-363
134. Sadanala, K.C., Chaturvedi, P.K., Seo, Y.M., Kim, J.M., Jo, Y.S., Lee, Y.K. and Ahn, W.S. (2014) Sono-photodynamic combination therapy: A review on sensitizers. Anticancer Res. 34, 4657-4664
135. Kessel, D. (1986) Photosensitization with derivatives of haematoporphyrin. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 49, 901-907
136. Lee, P.K. and Kloser, A. (2013) Current methods for photodynamic therapy in the US: comparison of MAL/PDT and ALA/PDT. J. Drugs Dermatol. 12, 925-930
137. Liu, A.H., Sun, X., Wei, X.Q. and Zhang, Y.Z. (2013) Efficacy of multiple low-dose photodynamic TMPYP4 therapy on cervical cancer tumour growth in nude mice. Asian Pac. J. Cancer Prev. 14, 5371-5374
138. Maisch, T., Bosl, C., Szeimies, R.M., Lehn, N. and Abels, C. (2005) Photodynamic effects of novel XF porphyrin derivatives on prokaryotic and eukaryotic cells. Antimicrob. Agents Chemother. 49, 1542-1552
139. Senge, M.O. and Brandt, J.C. (2011) Temoporfin (Foscan(R), 5, 10, 15, 20-Tetra(m-hydroxyphenyl)chlorin)-A second-generation photosensitizer. Photochem. Photobiol. 87, 1240-1296
140. Muragaki, Y., Akimoto, J., Maruyama, T., Iseki, H., Ikuta, S., Nitta, M., Maebayashi, K., Saito, T., Okada, Y., Kaneko, S. et al. (2013) Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors. J. Neurosurg. 119, 845-852
141. Shafirstein, G., Rigual, N.R., Arshad, H., Cooper, M.T., Bellnier, D.A., Wilding, G., Tan, W., Merzianu, M. and Henderson, B.W. (2015) Photodynamic therapy with 3-(1'-hexyloxyethyl) pyropheophorbide-A for early-stage cancer of the larynx: phase Ib study. Head Neck
142. Moore, C.M., Azzouzi, A.R., Barret, E., Villers, A., Muir, G.H., Barber, N.J., Bott, S., Trachtenberg, J., Arumainayagam, N., Gaillac, B. et al. (2015) Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-Targeted photodynamic (VTP) therapy. BJU Int. 116, 888-896
143. Huang, L., Huang, Y.Y., Mroz, P., Tegos, G.P., Zhiyentayev, T., Sharma, S.K., Lu, Z., Balasubramanian, T., Krayer, M., Ruzie, C. et al. (2010) Stable synthetic cationic bacteriochlorins as selective antimicrobial photosensitizers. Antimicrob. Agents Chemother. 54, 3834-3841
144. Soriano, J., Villanueva, A., Stockert, J.C. and Canete, M. (2013) Vehiculization determines the endocytic internalization mechanism of Zn(II)-phthalocyanine. Histochem. Cell Biol. 139, 149-160
145. Stern, S.J., Flock, S.T., Small, S., Thomsen, S. and Jacques, S. (1990) Photodynamic therapy with chloroaluminum sulfonated phthalocyanine in the rat window chamber. Am. J. Surg. 160, 360-364
146. Simonetti, O., Cirioni, O., Orlando, F., Alongi, C., Lucarini, G., Silvestri, C., Zizzi, A., Fantetti, L., Roncucci, G., Giacometti, A. et al. (2011) Effectiveness of antimicrobial photodynamic therapy with a single treatment of RLP068/Cl in an experimental model of Staphylococcus aureus wound infection. Br. J. Dermatol. 164, 987-995
147. Jajarm, H.H., Falaki, F., Sanatkhani, M., Ahmadzadeh, M., Ahrari, F. and Shafaee, H. (2015) A comparative study of toluidine blue-mediated photodynamic therapy versus topical corticosteroids in the treatment of erosive-Atrophic oral lichen planus: A randomized clinical controlled trial. Lasers. Med. Sci. 30, 1475-1480
148. Cincotta, L., Foley, J.W., MacEachern, T., Lampros, E. and Cincotta, A.H. (1994) Novel photodynamic effects of a benzophenothiazine on two different murine sarcomas. Cancer Res. 54, 1249-1258
149. Ali, M.F. (2011) Topical delivery and photodynamic evaluation of a multivesicular liposomal Rose Bengal. Lasers Med. Sci. 26, 267-275
150. Shafeekh, K.M., Soumya, M.S., Rahim, M.A., Abraham, A. and Das, S. (2014) Synthesis and characterization of near-infrared absorbing water soluble squaraines and study of their photodynamic effects in DLA live cells. Photochem. Photobiol. 90, 585-595
151. Rice, D.R., Gan, H. and Smith, B.D. (2015) Bacterial imaging and photodynamic inactivation using zinc(ii)-dipicolylamine BODIPY conjugates. Photochem. Photobiol. Sci. 14, 1271-1281
152. Carpenter, B.L., Situ, X., Scholle, F., Bartelmess, J., Weare, W.W. and Ghiladi, R.A. (2015) Antiviral, antifungal and antibacterial activities of a BODIPY-based photosensitizer. Molecules 20, 10604-10621
153. Lei, W., Zhou, Q., Jiang, G., Zhang, B. and Wang, X. (2011) Photodynamic inactivation of Escherichia coli by Ru(II) complexes. Photochem. Photobiol. Sci. 10, 887-890
154. Knoll, J.D. and Turro, C. (2015) Control and utilization of ruthenium and rhodium metal complex excited states for photoactivated cancer therapy. Coord. Chem. Rev. 282-283, 110-126
155. Maggioni, D., Galli, M., D'Alfonso, L., Inverso, D., Dozzi, M.V., Sironi, L., Iannacone, M., Collini, M., Ferruti, P., Ranucci, E. and D'Alfonso, G. (2015) A luminescent poly(amidoamine)-iridium complex as a new singlet-oxygen sensitizer for photodynamic therapy. Inorg. Chem. 54, 544-553
156. Tonon, C.C., Paschoal, M.A., Correia, M., Spolidorio, D.M., Bagnato, V.S., Giusti, J.S. and Santos-Pinto, L. (2015) Comparative effects of photodynamic therapy mediated by curcumin on standard and clinical isolate of Streptococcus mutans. J. Contemp. Dent. Pract. 16, 1-6
157. Goff, B.A., Hermanto, U., Rumbaugh, J., Blake, J., Bamberg, M. and Hasan, T. (1994) Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model. Br. J. Cancer 70, 474-480
158. Demidova, T.N. and Hamblin, M.R. (2005) Effect of cell-photosensitizer binding and cell density on microbial photoinactivation. Antimicrob. Agents Chemother. 49, 2329-2335
159. Demidova, T.N. and Hamblin, M.R. (2004) Macrophage-Targeted photodynamic therapy. Int. J. Immunopathol. Pharmacol. 17, 117-126
160. El-Akra, N., Noirot, A., Faye, J.C. and Souchard, J.P. (2006) Synthesis of estradiol-pheophorbide a conjugates: evidence of nuclear targeting, DNA damage and improved photodynamic activity in human breast cancer and vascular endothelial cells. Photochem. Photobiol. Sci. 5, 996-999
161. Ballut, S., Makky, A., Chauvin, B., Michel, J.P., Kasselouri, A., Maillard, P. and Rosilio, V. (2012) Tumor targeting in photodynamic therapy. From glycoconjugated photosensitizers to glycodendrimeric one. Concept, design and properties. Org. Biomol. Chem. 10, 4485-4495